Alveolar macrophages (AM) also known as dust cells are a type of white blood cells. The immune system is divided into the cellular and humoral components. Alveolar macrophages are the first line of defense against invading respiratory pathogens. They reside in pulmonary alveoli and the inter-alveolar septum in close proximity with pneumocytes. The alveoli are the terminal unit of the respiratory system responsible for gaseous exchange. The alveoli are comprised of three different kinds of cells: (1) Type I pneumocytes, build up the structure of the alveolar wall and aid in respiration. They do not replicate. (2) Type II pneumocytes secrete a lipoprotein called surfactant that prevents the collapse of the alveoli even after exhalation. (3) Alveolar macrophages produce a variety of signaling chemicals that interact with other cells of the immune system to orchestrate a response that maintains immunologic and tissue homeostasis in the body. Type II pneumocytes replete both types of pneumocytes and AMs which in turn are vital to host defenses and tissue remodeling.
All cell types of the mononuclear phagocyte system originate from the hematopoietic stem cells produced in bone marrow from the common myeloid progenitor. These myeloid cells further differentiate into myeloblasts that give rise to monocytes. Monocytes travel in the bloodstream and get matured in the connective tissue of the organ to form macrophages. Alveolar macrophages also can be present in the tissue from birth, independent of monocytes. Monocytes have a half-life of a day, whereas macrophages can live up to months or years in the tissue. The size or shape of alveolar macrophages can vary among different individuals depending on the phagocytic function and the living environment of the cell in the body. The cell membrane of alveolar macrophages can change its shape during mobilization or phagocytosis by the activation of the microtubule network. The movement of alveolar macrophages to the site of tissue injury in response to certain chemicals is known as chemotaxis. Alveolar macrophages have a very distinct actin microfilament structure that aids in chemotaxis and endocytosis.
Alveolar macrophages play an important role in scavenging microbes such as viruses, bacteria, fungi, inhaled environmental particles like coal, silica, asbestos, tissue debris, and cancer cells. Alveolar macrophages get activated by the interaction of toll-like receptors (TLR) present on the AM surface with the pathogen-associated molecular receptors (PAMP) present on the microbial cell. The interplay between TLRs and PAMPs transmits chemical signals that trigger the process of pathogen engulfment and the secretion of pro-inflammatory cytokines that enhance local immune response. After phagocytosis, phagosomes are fused with lysosomes to form phagolysosomes and production of digestive enzymes that kill the pathogen. Certain bacteria such as Mycobacterium Tuberculosis can resist phagocytosis. In such case, alveolar macrophages contain the infection from spreading to the other organs. Specific environmental particles like carbon and silica can be engulfed by macrophages in an attempt to keep them out of the bloodstream. During an active inflammatory reaction, certain pro-inflammatory cytokines play an important part in tissue repair and fibrosis.
Resting macrophages are difficult to stain on hematoxylin and eosin (H&E) preparations. One way for a practitioner to visualize them is to inject an experimental animal with very fine carbon particles. The engulfed carbon particles become visible as a dark, black-brown accumulation in the cytoplasm of the alveolar macrophages. However, according to some studies, alveolar macrophages are more easily identifiable in pulmonary tissue sections than macrophages in other tissues of the body.
Cells are differentiated from the surrounding tissue by using a cluster of differentiation (CD) markers or the cell's surface molecules. There is no specific CD marker for alveolar macrophages. The cell recognition depends on the tissue in which macrophages need to be detected, and the antibody can be tailored accordingly. CD11b and CD68 are associated with macrophages in the literature. In one study, there is an increasing percentage of CD63, CD204, or CD206 positive cells found in the lungs of patients with chronic obstructive pulmonary disease (COPD) compared to those in nonsmokers and smokers.
In a healthy lung, there are at least two types of macrophages: alveolar macrophages (AM) and interstitial macrophages (IM). They are functionally different and can be distinguished by localization within the lung and expression of CD11b and CD11c. After exposure to a pathogen, polarized alveolar macrophages are divided into M1 cells and M2 cells. M1 cells produce pro-inflammatory mediators like TNF-alpha and IL-1beta. M2 cells further differentiate and dominantly produce allergic cytokines IL-4 and IL-13; these are involved in the pathological mechanism of asthma. One study established the role of IL-17 in allergic asthma. IL-17 is produced by alveolar macrophages and causes airway remodeling in patients with asthma.
Under the electron microscope, alveolar macrophages contain all the vital cell organelles like variable shape nucleus with nucleoli, ribosomes, Golgi bodies, mitochondria, and most importantly, the lysosomes. Lysosomes contain digestive enzymes that help breakdown engulfed material.
Alveolar macrophages play an important role in infections such as tuberculosis (TB). Mycobacterium tuberculosis’ bacteria evolved mechanisms that resist phagocytosis of macrophages. Alveolar macrophages gather around the M. Tuberculosis and join to form a multinucleated giant cell (also known as Langerhans giant cell), surrounded by T-cells. TNF-alpha and IFN- gamma are particularly important in the formation of granuloma. TB is one of leading cause of mortality and morbidity in patients with HIV, especially in underdeveloped countries where HART is not widely available. The hallmark finding of non-caseating granulomas in some of the systemic diseases such as sarcoidosis form by joining alveolar macrophages in an attempt to wall-off the infectious process. Alveolar macrophages also secrete vitamin D and cause hypercalcemia in sarcoidosis, one of the clinical criteria that help in diagnosis.
Alveolar macrophages also engulf harmful environmental particles such as carbon, specifically reported in coal mine workers and termed as pneumoconiosis. Similarly, crystalline silica particles can deactivate alveolar macrophages immunologic response, mimicking TB. For this reason, patients with a history of silica exposure should have periodic TB testing.
Alveolar macrophages also are found in higher numbers higher in the bronchoalveolar lavage (BAL) collected from the lungs of patients who smoke and those with COPD. The macrophage count obtained by lavage is found to be four to six times greater in smokers than nonsmokers. Apart from this, alveolar macrophages are morphologically different and contain a higher amount of harmful pigment and free radicals in smokers than in non-smokers. Emphysema is a chronic lung disease caused by the destruction of terminal airways by elastases, secreted by neutrophils. Interestingly, alveolar macrophages secrete elastases too, therefore elastases also are high in the lavage of smokers. In that aspect, the role of alveolar macrophages in emphysema can give more insight into the disease process and a new avenue for research.
Alveolar macrophages are involved in interstitial pulmonary fibrosis (IPF), a condition in which lung tissue is replaced by fibrotic tissue. Fibroblasts are absent in healthy lung tissue but have been found in the BAL fluid of the IPF.
In some studies, fibroblasts are considered a subset of alveolar macrophages as they express the same monocyte surface markers such as CD11b and CD14. Surfactants are phospholipids produced by pneumocytes that prevent the collapse of alveolar walls during expiration. Another function of alveolar macrophages is to remove excess surfactant and thus maintain homeostasis. Alveolar macrophages require stimulation from a signaling molecule known as granulocyte/macrophage-colony stimulating factor (GM-CSF) to clear excess surfactant. Pulmonary alveolar proteinosis (PAP) is a spectrum of autoimmune diseases in which antibodies are formed against GM-CSF, halting the function of alveolar macrophages thus building up excess surfactant. A hereditary form of PAP is a rare condition that presents in children between the ages of one and 10 years, resulting from the mutation of GM-CSF receptors on alveolar macrophages. In short, alveolar macrophages play an important role in the body's defense against pathogens, foreign bodies, walling-off infections, and repair.